{{Rsnum
|rsid=2249695
|Gene=CYP2E1
|Chromosome=10
|position=135352168
|Orientation=plus
|GMAF=0.4045
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 54.0 | 42.5 | 3.5
| HCB | 33.6 | 47.4 | 19.0
| JPT | 29.2 | 53.1 | 17.7
| YRI | 4.8 | 37.4 | 57.8
| ASW | 10.5 | 49.1 | 40.4
| CHB | 33.6 | 47.4 | 19.0
| CHD | 41.3 | 50.5 | 8.3
| GIH | 31.7 | 52.5 | 15.8
| LWK | 2.8 | 35.8 | 61.5
| MEX | 67.2 | 24.1 | 8.6
| MKK | 10.9 | 50.0 | 39.1
| TSI | 55.4 | 37.6 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19805575
|Title=A Case-Control and a Family-Based Association Study Revealing an Association between CYP2E1 Polymorphisms and Nasopharyngeal Carcinoma Risk in Cantonese
|OA=1
}}

{{PMID Auto
|PMID=21940907
|Title=Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer
|OA=1
}}

{{PMID Auto
|PMID=17160896
|Title=Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}